Abstract:
Compounds of the formula ##STR1## in which A is lower alkyl, or a substituted or unsubstituted phenyl, thienyl, furyl, indolyl or thiaindolyl radical, R, X.sub.4 and X.sub.5 are hydrogen or lower alkyl, Y is hydrogen, hydroxy, etherified hydroxy, substituted amino, or N-attached heterocyclyl, X.sub.0 is O or OCH.sub.2 CH.sub.2 O, R' represents hydrogen, lower alkyl or acetyl; and acid-addition salts thereof, are novel and useful in pharmacy as hypolipaemiant, hypocholesterolaemiant and cholagogic agents or in the preparation of such agents.
Abstract:
Disclosed are monomers of the formula: ##STR1## WHEREIN R is ##STR2## R' is hydrogen or methyl; R" is alkyl of 1-10 carbon atoms;X and Y are independently selected from the group consisting of NO.sub.2, halogen, cyano and --CF.sub.3 ;Z is oxygen or dicyanomethylene;a and a' can range from 0-3; andn is 1-10.These monomers can be readily polymerized to polymers suitable for use in electrophotographic imaging members and methods.
Abstract:
A process for the isolation of mixtures of 1,5-dinitroanthraquinone and 1,8-dinitroanthraquinone which have a high content of .alpha.,.alpha.'-dinitroanthraquinones by heating a suspension of the crude dinitroanthraquinone mixture in certain organic liquids at from 60.degree. to 200.degree. C until solution equilibrium has been set up, and separating the undissolved material from the solution. The undissolved material contains more than 90% and as a rule more than 95% by weight of 1,5-dinitroanthraquinone and 1,8-dinitroanthraquinone. The pure mixture of 1,5-dinitroanthraquinone and 1,8-dinitroanthraquinone may be used for the manufacture of dyes.
Abstract:
A compound of the formula: ##STR1## wherein Z is ethyl or vinyl,R.sub.1 and R.sub.2 are hydrogen, lower alkyl, lower alkenyl or trihalomethyl,R.sub.3 and R.sub.4 are hydrogen, lower alkyl, lower alkenyl, trihalomethyl, cyclopentyl, benzyl or phenyl, andR.sub.5 is lower alkyl, lower alkenyl, trihalomethyl, cyclopentyl, benzyl, or phenyl with the proviso that where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 each is hydrogen, R.sub.5 is not methyl attached to the 4-position of the benzene ring, or a pharmaceutically acceptable acid addition or quaternary ammonium salt thereof is disclosed as effective in the regulation of the liver microsomal enzyme system.
Abstract:
New 4-aminopyrimidium derivatives of the general formula: ##STR1## wherein R.sub.1 and R.sub.2 each represents a hydrogen atom or a lower alkyl group, and R.sub.3 and R.sub.4 each represents a hydrogen or halogen atom, a lower alkyl, a lower alkoxyl, a lower alkoxycarbonyl, a lower alkylsulfonyl, nitro or amino group, and X represents a halogen atom, as well as a process for the preparation thereof. The compounds are useful as anti-inflammatory, analgesic agents without producing gastrointestinal trouble.
Abstract:
An adiabatic process for the mononitration of nitratable aromatic hydrocarbons and halo substituted aromatic hydrocarbons which yield a mononitration product containing less than 500 ppm. of dinitrated product is disclosed.
Abstract:
2-NITROBENZALDEHYDE, A VALUABLE CHEMICAL INTERMEDIATE, IS PREPARED THROUGH THE OXIDATION OF AN ALKALI METAL SALT OF 2-NITROPHENYLPYRUVIC ACID WITH POTASSIUM PERMANGANATE IN AN ALKALINE MEDIUM. Advantageously the requisite starting material is prepared directly by the reaction of 2-nitrotoluene and a diester of oxalic acid in the presence of an alcoholate and is then subjected to the oxidation without isolation. In a preferred embodiment the oxidation reaction mixture is acidified to convert the manganese-(IV) oxide to soluble maganese-(II) salts with concurrent conversion of oxalic acid to carbon dioxide. The process is industrially attractive in terms of the high yield, the availability of starting material and the ease of the manipulative steps involved.
Abstract:
A pharmaceutical composition is produced which is useful for treating allergic conditions in humans which comprises an anti-allergenic amount of a compound of the formula: ##SPC1##Or a pharmaceutically acceptable salt or ester thereof, wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are the same or different and each is hydrogen, alkyl, alkoxy, aryl, aralkyl or halogen or any two of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 taken together, with the carbon atoms to which they are attached, form a phenyl, cyclohexyl or cyclohexenyl ring, in combination with a pharmaceutically acceptable carrier.
Abstract:
This invention relates to an improvement in an process for dinitrating 3-nitrobenzotrifluoride and 4-hal0-3-nitrobenzotrifluoride compounds wherein the mononitrobenzotrifluoride composition is contacted with a mixture comprising sulfuric and nitric acid. The improvement constituting the basis of this invention comprises carrying out the dinitration with the sulfuric acid being present in at least a catalytic proportion but not exceeding about 65 mole percent in said mixture.